UNITY Biotechnology to Participate in Upcoming September Investor Conferences
September 04 2020 - 8:00AM
UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company
developing therapeutics to extend healthspan by slowing, halting or
reversing diseases of aging, today announced that members of its
senior management team will participate in the following upcoming
September investor conferences:
Citi 15th Annual BioPharma Virtual
ConferenceDate: September 9, 2020Location: Virtual – 1x1
only
Morgan Stanley 18th Annual Global Healthcare
ConferenceDate: September 15, 2020Fireside Chat Time: 4:15
PM E.T.Location: Virtual
Cantor Fitzgerald Virtual Healthcare Conference
ConferenceDate: September 16, 2020Presentation Time: 10:00
AM E.T.Location: Virtual
A live audio webcast of the fireside chat and presentation from
the Morgan Stanley and Cantor Fitzgerald conferences will be
available through the Investors & Media section of UNITY’s
website. An archived replay will be available for 90 days following
each event.
About UNITYUNITY is developing a new class of
therapeutics to slow, halt or reverse diseases of aging. UNITY's
initial focus is on creating medicines to selectively eliminate or
modulate senescent cells and thereby provide transformative benefit
in age-related diseases, such as osteoarthritis, eye diseases,
neurological diseases and pulmonary diseases. More information is
available at www.unitybiotechnology.com or follow us
on Twitter.
Investors
Endurance Advisors
Mike Zanoni
mzanoni@enduranceadvisors.com
Media
Canale Communications
Jason Spark
jason@canalecomm.com
UNITY Biotechnology (NASDAQ:UBX)
Historical Stock Chart
From Aug 2024 to Sep 2024
UNITY Biotechnology (NASDAQ:UBX)
Historical Stock Chart
From Sep 2023 to Sep 2024